AbbVie Inc and Shire Plc reach agreement on terms of recommended combination

AbbVie Inc and Shire Plc:Says they have reached agreement on the terms of a recommended combination of Shire with AbbVie.Under the terms of the Merger, Shire shareholders will be entitled to receive: for each Shire Share: 24.44 Pounds in cash and 0.8960 New AbbVie Shares.Immediately following the...

Friday, 18 Jul 2014 05:00am EDT

AbbVie Inc and Shire Plc reach agreement on terms of recommended combination

AbbVie Inc and Shire Plc:Says they have reached agreement on the terms of a recommended combination of Shire with AbbVie.Under the terms of the Merger, Shire shareholders will be entitled to receive: for each Shire Share: 24.44 Pounds in cash and 0.8960 New AbbVie Shares.Immediately following the...

Friday, 18 Jul 2014 05:00am EDT

Swedish Orphan Biovitrum publ AB maintains FY 2014 financial guidance

Swedish Orphan Biovitrum publ AB:Says it continues to expect the company's total revenues for FY 2014 to be in the range of between 2,300 mln Swedish crowns and 2,500 mln crowns.FY 2014 gross margin is expected to be in the range of between 58 pct and 60 pct.In addition, operating costs are expected...

Friday, 18 Jul 2014 02:00am EDT

Amgen announces positive phase 3 results for AMG 416 for treatment of secondary hyperparathyroidism in patients with chronic kidney disease receiving hemodialysis

Amgen Inc:Announced that a Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints.Primary endpoint was the proportion of patients with 30 percent...

Thursday, 17 Jul 2014 04:01pm EDT

Restructuring & Reorganization

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.